3 participants
A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves Through the Bodies of Adult Chinese Participants With Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-17
- Start Date:
- 2024-09-11
- Completion:
- 2027-02-28
Conditions
- Hepatocellular Carcinoma (HCC)
Interventions
- DRUG
No Results Yet